[HTML][HTML] Incidence and risk factors for early hepatotoxicity and its impact on survival in patients with myelofibrosis undergoing allogeneic hematopoietic cell …
KM Wong, EG Atenafu, D Kim, J Kuruvilla… - Biology of Blood and …, 2012 - Elsevier
Allogeneic hematopoietic cell transplantation (HCT) is commonly associated with hepatic
complications. Patients with myelofibrosis (MF) often develop liver dysfunction in the early …
complications. Patients with myelofibrosis (MF) often develop liver dysfunction in the early …
Graft-versus-host disease and impact on relapse in myelofibrosis undergoing hematopoietic stem cell transplantation
S Oechsler, N Gagelmann, C Wolschke… - Bone Marrow …, 2024 - nature.com
Allogeneic hematopoietic stem cell transplantation (alloHSCT) remains the only curative
treatment for myelofibrosis (MF). Relapse occurs in 10–30% and remains a major factor for …
treatment for myelofibrosis (MF). Relapse occurs in 10–30% and remains a major factor for …
Early post-transplantation factors predict survival outcomes in patients undergoing allogeneic hematopoietic cell transplantation for myelofibrosis
Factors predicting allogeneic hematopoietic cell transplantation (HCT) outcomes in
myelofibrosis in the early post-HCT period have not been defined thus far. We attempt to …
myelofibrosis in the early post-HCT period have not been defined thus far. We attempt to …
Incidence and risk factors of poor graft function after allogeneic stem cell transplantation for myelofibrosis
H Alchalby, DR Yunus, T Zabelina, F Ayuk… - Bone Marrow …, 2016 - nature.com
Allogeneic hematopoieteic stem cell transplantation (HSCT) is the only curative treatment for
myelofibrosis (MF), but it is still associated with significant risks and complications. One of …
myelofibrosis (MF), but it is still associated with significant risks and complications. One of …
[HTML][HTML] Long-term outcome after allogeneic hematopoietic cell transplantation for myelofibrosis
M Robin, LC De Wreede, C Wolschke, J Schetelig… - …, 2019 - ncbi.nlm.nih.gov
Allogeneic hematopoietic stem cell transplant remains the only curative treatment for
myelofibrosis. Most post-transplantation events occur during the first two years and hence …
myelofibrosis. Most post-transplantation events occur during the first two years and hence …
Outcomes following second allogeneic haematopoietic cell transplantation in patients with myelofibrosis: a retrospective study of the Chronic Malignancies Working …
Therapeutic management of patients with primary or secondary myelofibrosis (MF) who
experience relapse or graft failure following allogeneic haematopoietic cell transplantation …
experience relapse or graft failure following allogeneic haematopoietic cell transplantation …
Determinants of survival in myelofibrosis patients undergoing allogeneic hematopoietic cell transplantation
JC Hernández-Boluda, A Pereira, N Kröger, D Beelen… - Leukemia, 2021 - nature.com
We aimed to evaluate the determinants of survival in myelofibrosis patients undergoing
allogeneic hematopoietic cell transplantation (allo-HCT) and to describe factors predicting …
allogeneic hematopoietic cell transplantation (allo-HCT) and to describe factors predicting …
A simple prognostic system in patients with myelofibrosis undergoing allogeneic stem cell transplantation: a CIBMTR/EBMT analysis
R Tamari, DP McLornan, KW Ahn… - Blood …, 2023 - ashpublications.org
To develop a prognostic model for patients undergoing allogeneic hematopoietic cell
transplantation (allo-HCT) for myelofibrosis (MF), we examined the data of 623 patients …
transplantation (allo-HCT) for myelofibrosis (MF), we examined the data of 623 patients …
Outcome of patients with Myelofibrosis relapsing after allogeneic stem cell transplant: a retrospective study by the Chronic Malignancies Working Party of EBMT
DP McLornan, R Szydlo, M Robin… - British journal of …, 2018 - Wiley Online Library
Summary Allogeneic Haematopoietic Stem Cell Transplant (allo‐HSCT) remains the only
curative approach for Myelofibrosis (MF). Scarce information exists in the literature on the …
curative approach for Myelofibrosis (MF). Scarce information exists in the literature on the …
[HTML][HTML] Dynamic International Prognostic Scoring System scores, pre-transplant therapy and chronic graft-versus-host disease determine outcome after allogeneic …
M Ditschkowski, AH Elmaagacli, R Trenschel… - …, 2012 - ncbi.nlm.nih.gov
Background Myelofibrosis is a myeloproliferative stem cell disorder curable exclusively by
allogeneic hematopoietic stem cell transplantation and is associated with substantial …
allogeneic hematopoietic stem cell transplantation and is associated with substantial …
相关搜索
- allogeneic transplant patients with myelofibrosis
- early hepatotoxicity survival in patients
- early hepatotoxicity cell transplantation
- myelofibrosis patients cell transplantation
- early hepatotoxicity risk factors
- survival in patients risk factors
- risk factors cell transplantation
- myelofibrosis patients determinants of survival
- determinants of survival cell transplantation
- myelofibrosis relapsing outcome of patients
- survival in patients cell transplantation
- survival outcomes cell transplantation